Home   |  Publications   |   Conferences    |  Join   |   Contact   | Sitemap  

Journal of Membrane Science & Technology

Open Access
ISSN: 2155-9589
home » essential-role-of-phospholipase-cg-in-hypoxiainduced-pulmonary-vasoconstriction-and-hypertension-2155-9589 Rss Feed Rss Feed
Editorial Open Access
Essential Role of Phospholipase C-g1 in Hypoxia-Induced Pulmonary Vasoconstriction and Hypertension
Center for Cardiovascular Sciences, Albany Medical College, Albany, New York, USA Vishal R Yadav, Center for Cardiovascular Sciences, Albany Medical College, Albany, New York, USA Yun-Min Zheng and Center for Cardiovascular Sciences, Albany Medical College, Albany, New York, USA Yong-Xiao Wang*
Corresponding Author : Dr. Yong-Xiao Wang
Center for Cardiovascular Sciences
Albany Medical College, Albany, New York, USA
E-mail: wangy@mail.amc.edu
Received June 13, 2013; Accepted June 16, 2013; Published June 18, 2013
Citation: Yadav VR, Zheng YM, Wang YX (2013) Essential Role of Phospholipase C-g1 in Hypoxia-Induced Pulmonary Vasoconstriction and Hypertension. J Membra Sci Technol 3:e115. doi: 10.4172/2155-9589.1000e115
Copyright: © 2013 Yadav VR, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at
DownloadPubmed DownloadScholar Google
Visit for more related articles at
DownloadJournal of Membrane Science & Technology
Hypoxia-induced Pulmonary Vasoconstriction (HPV) is an essential physiological process which ensures proper ventilationperfusion matching in pulmonary circulation with the ultimate aim of optimizing systemic oxygen delivery. However, this cellular response can become a key pathological process leading to pulmonary artery hypertension and right heart failure. An increase in intracellular calcium concentration ([Ca2+]i) in Pulmonary Artery Smooth Muscle Cells (PASMCs) plays a crucial role in producing HPV. However, the underlying signaling mechanisms are not completely understood [1-3]. Thus, the identification of the molecular players involved in HPV is imperative for a deeper and broader understanding of hypoxic pulmonary artery hypertension and other related diseases.
Phospholipase C (PLC) is a key enzyme family for numerous physiological and pathological cellular responses in the cardiovascular system. On activation, PLC hydrolyses the plasma membranebound phosphatidylinositol bisphosphate (PIP2) into inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 opens IP3 receptors (IP3Rs) on the Sarcoplasmic Reticulum (SR) membrane to induce Ca2+ release. DAG activates protein kinase C to lead Ca2+- dependent cellular responses. Among all known isoforms, PLCγ1 has shown to be highly expressed in the lungs [4], and involved in reactive oxygen species (ROS)-evoked increase in [Ca2+]i in PC-12 cell line [5], cultured human venous SMCs [6] and cultured rat astrocytes [7]. ROS are known to be critical for the hypoxic increase in [Ca2+]i in PAMSCs [1,8]. Taken together, it was conjectured that PLCγ1 would be a major regulator in the hypoxic increase in [Ca2+]i in PASMCs and HPV.
We conducted a series of experiments to test the aforementioned exciting assumption. Our data have revealed that PLCγ1 is activated in pulmonary arteries following acute hypoxic exposure. Equally importantly, lentiviral shRNA-mediated knock-down of PLCγ1 or pharmacological inhibition of PLC significantly reduces hypoxiainduced increase in [Ca2+]i in PASMCs and HPV [9]. It is interesting to note that PLCγ1 enhances survival of MEF cells [10] and cardiomycytes during oxidative stress [11]. Patterson and coworkers have reported that PLCγ is required for agonist-induced Ca2+ entry in PC12 and A7r5 cells by controlling TRPC3 trafficking and expression on the plasma membrane [12,13]. Homozygous PLCγ1 gene knockout mice show the early embryonic lethality [14], further reinforcing the functional importance of PLCγ1.
Our very recent studies have further unveiled that acute hypoxic exposure causes significant phosphorylation of PLCγ1 at tyrosine 783, which is regarded as vital for activation of PLCγ1 [15], in PASMCs [9]. Gene silencing of Rieske Iron-Sulfur Protein (RISP) to inhibit ROS generation at the mitochondrial complex III [8] fully abolishes the acute hypoxic phosphorylation of PLCγ1 [9]. Similarly, treatment with the mitochondrial complex III inhibitor myxothiazol to block ROS generation [16-18] completely inhibits the hypoxic response as well. Collectively, the hypoxic activation of PLCγ1 in PASMCs is mediated by RISP-dependent mitochondrial ROS production. Whether or not hypoxic activation of PLCγ1 is directly dependent on ROS or ROS mediated interplay molecules is a matter of further investigation. Nevertheless, targeting PLCγ1 on the plasma membrane may provide a viable and important approach in developing new and more effective therapeutic strategies for hypoxic pulmonary artery hypertension and other related diseases.



 Download    pdf version of this article


Select your language of interest to view the total content in your interested language
Share This Article
About Journal
Disc Journal Home
Disc Editorial Board Members
Disc Current Issue
Disc Previous Issue
Disc Instructions for Authors
Disc Submit Manuscript
Disc Contact Editorial Office
Related Journals
Disc Journal of Biomimetics Biomaterials and Tissue Engineering
Disc Journal of Biotechnology & Biomaterials
Disc Current Synthetic and Systems Biology
Related Conferences
Disc 6th World Congress on Biotechnology May 25-27, 2015 Canada
Disc 5th World congress on Biotechnology June 25-27, 2014 Valencia, Spain
Article Tools
Disc Export citation
Disc Share/Blog this article
Disc Recommend to your Librarian
Article usage
  Total views: 7838
  [From(publication date):
September-2013 - Jun 02, 2015]
  Breakdown by view type
  HTML page views : 7059
  PDF downloads :779
Subject wise
Open Access Journals
Disc Clinical Journals
Disc Chemistry Journals
Disc Engineering Journals
Disc Environmental Journals
Disc Life Sciences Journals
  Read More »
Meet us at our 300+ Global Events in Pharma, Medicine, Science and Technology

Our 2015 Major destinations:
Conferences By Country
   USA    Spain
   Australia   Canada
   UAE   China
   Italy   France
   Germany   India
   UK   Malaysia
   Japan   Singapore
   Brazil   South Africa
  South Korea
Conferences By City
Chicago Valencia Beijing
Florida Alicante Houston
Philadelphia Rome San Antonio
Baltimore Birmingham Abu Dhabi
Boston Lexington Las Vegas
Seattle Atlanta Barcelona
New Orleans Brisbane San Francisco
Bengaluru New Delhi Toronto
Dubai London Hyderabad
Conferences By Subject
Medical Pharma Veterinary
Agri, Food & Aqua Genetics Molecular Biology
Physics Health care Neuroscience
Chemistry Immunology Nursing
Clinical Massmedia Physics
Environmental Materials Science Microbiology
EEE Environmental  
Chemical Engineering Business & Management
20082014 OMICS Group - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version